News

FDA’s Prasad Exits Following Political Backlash Over Sarepta
Vinay Prasad, a top regulator at the US Food and Drug Administration, ended his short tenure at the agency after conservative pundits including Laura Loomer and Rick Santorum led a crusade against him ...
BioPharma Dive43m
Vinay Prasad’s ouster leaves biotech guessing at FDA direction
The abrupt exit of the former CBER director, who quickly made his mark at the agency with several high-profile and ...
FDA vaccines head, chief medical officer Vinay Prasad departs agency
Vinay Prasad, who headed the U.S. FDA division in charge of vaccines and was also chief medical and scientific officer, has ...
FDA chief scientific officer Vinay Prasad resigns
Dr. Vinay Prasad, the chief scientific officer at the Food and Drug Administration, has resigned after only three months in ...
The New York Sun1h
FDA’s Top Regulator Is Out Amid MAHA Backlash Over Blocking Access to a $3.2 Million Per Dose Therapy for Rare Disorder in Boys
Vinay Prasad, who came under fire from patient advocacy groups and Laura Loomer, is gone after less than three months on the ...
Fierce Biotech3h
FDA misses IND deadline for Coya’s ALS asset, cites lack of resources
The FDA has missed the date for Coya Therapeutics’ investigational new drug (IND) application, citing a lack of resources and ...
Controversial vaccine official Dr. Vinay Prasad departs FDA
Dr. Vinay Prasad had been serving as the FDA's director of the Center for Biologics Evaluation and Research since May, and was later named chief medical and scientific officer.
MedPage Today4h
FDA's Top Vaccine Chief Resigns
After just a few controversial months, Vinay Prasad, MD, MPH, has stepped down as director of FDA's Center for Biologics ...
Vinay Prasad, controversial FDA official, abruptly departs agency
Prasad's exit ends a tumultuous tenure during which he led a reworking of agency guidelines on COVID vaccines and his office ...